San Francisco, CA (PRWEB) March 07, 2013
Real Time Genomics, Inc., the genome analytics company, today announced the formation of its Scientific Advisory Board (SAB) to provide guidance and expertise as the company develops tools to improve the accuracy and utility of genomic sequencing in the research of human disease.
Founding members of the SAB include Dr. George Weinstock, Associate Director of The Genome Institute at Washington University School of Medicine, Dr. Timothy Triche, Director of the Center for Personalized Medicine at Children’s Hospital Los Angeles and the Associate Director of the Pediatric Institute of Molecular Medicine at Phoenix Children’s Hospital, and Dr. Gene Myers, Director of the Center for Systems Biology at the Max Planck Institute, Dresden.
“We are very pleased to welcome three scientists as talented as George, Tim and Gene to our SAB,” said Steve Lombardi, Chief Executive Officer of Real Time Genomics. “Their track records of success in their respective fields are exemplary and reflect their status as world-class genomics scientists. Their addition to the leadership of RTG greatly expands our knowledge of the progress and direction of the technology, science and medical vectors that influence the adoption of genomics to both life science research and personalized medicine.”
“Real Time Genomics has assembled a exceptional team of scientific, engineering, and business leaders all focused on delivering the most accurate and cost effective results for medical and biological application,” said Dr. Weinstock, who will Chair the Scientific Advisory Board. “Their platform has proven to be accurate, reliable and robust. I am pleased to join RTG’s scientific advisory board and look forward to guiding the company as it pursues its important mission.”
Dr. Weinstock applies high-throughput DNA sequencing, genome-wide analysis, bioinformatics, and other genetic methods in his role
Copyright©2012 Vocus, Inc.
All rights reserved